entertainment -WSS

entertainment

author：comprehensive 2025-09-07 17:23:53 - browse：7

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： When prostate cancer spreads, where it goes matters

focus

leisure time

WSS

Ask STAT: What do you want to know about ChatGPT in medicine?

Cloning humans is technically possible. It's curious no one has tried

Ask STAT: What do you want to know about ChatGPT in medicine?

Do masks work? RCTs can't tell us

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Bird flu: Don't repeat Covid's 'health versus the economy' framing

hotspot

entertainment

leisure time

State Dept. review finds Biden bears some blame for Afghanistan failures

Helping hospitals and community health centers plan for resilience

Malaria cases in Florida and Texas: Here’s what you need to know

Gene therapy has helped boys walk. Can scientists keep it that way?

Supreme Court strikes down use of affirmative action

Second House panel advances two

Medicare proposal to cover medical devices draws a mixed reaction

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

After affirmative action ruling, medical educators look to 'holistic review'

Bird flu: Don't repeat Covid's 'health versus the economy' framing

focus

New guidelines on severe brain injury complicate already difficult decisions

Readout LOUD podcast: Live from STAT Breakthrough Summit West

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

HIV vaccine remains elusive. Immunologists keep trying new ideas

STAT's guide to the next generation of CAR

NVIDIA and Google execs on the future of AI and drug discovery

focus

leisure time

hotspot

hotspot